1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Global Oncology Molecular Diagnostics Market 2015-2019

Global Oncology Molecular Diagnostics Market 2015-2019

  • September 2015
  • -
  • Infiniti Research Limited
  • -
  • 63 pages

About oncology molecular diagnostics
Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.

Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.

Technavio's analysts forecast the global oncology molecular diagnostics market to grow at a CAGR of 17.8% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the global oncology molecular diagnostics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostics assay kits and instruments for cancers, which include:
- Breast
- Colorectal
- Prostate
- Others (including lung and cervical cancers)

Technavio's report, Global Oncology Molecular Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- APAC
- Europe
- Latin America
- MEA
- North America

Key Vendors
- Abbott Diagnostics
- Becton, Dickinson and Company
- QIAGEN
- Roche Diagnostics

Other prominent vendors
- Agendia
- Angsana Molecular and Diagnostics
- Asuragen
- Autogenomics
- Beckman Coulter
- bioMérieux
- bioTheranostics (Formerly AviaraDx)
- Cangen Biotechnologies
- Cepheid
- Diagnocure
- Epigenomics
- Eragen
- EXACT Sciences
- Exiqon
- GeneNews
- Genera Biosystems
- Genomic Health
- Genomix Biotech
- Health Discovery
- HTG Molecular
- Hologic
- Innogenetics
- Intergenetics
- Kreatech Holding
- Myriad Genetics
- Nanosphere
- NorDiag
- Nuvera Biosciences
- OncoMethylome Sciences
- Orion Genomics
- Prediction Sciences
- Predictive Biosciences
- Rosetta Genomics
- SensiGen
- Source MDx
- Vermillion

Market driver
- Increase in demand for personalized medicines
- For a full, detailed list, view our report

Market challenge
- Ethical, privacy, and practical issues
- For a full, detailed list, view our report

Market trend
- Advances in mass spectrometry
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Oncology Molecular Diagnostics Market 2015-2019
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Cancer statistics
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Reimbursement and coverage: An overview
PART 08: Molecular diagnostic products: Pricing scenario
PART 09: Market segmentation by cancer type
Breast cancer
Colorectal cancer
Prostate cancer
Other cancers
PART 10: Geographical segmentation
Oncology molecular diagnostics market in Americas
Oncology molecular diagnostics market in EMEA
Oncology molecular diagnostics market in APAC
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 17: Key vendor analysis
Abbott Diagnostics
Becton, Dickinson
Qiagen
PART 18: Explore Technavio


List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Snapshot of global oncology molecular diagnostics market 2015-2019
Exhibit 03: Prevalent cancers worldwide 2012
Exhibit 04: Countries with highest cancer rates 2012
Exhibit 05: Cancer by gender 2012
Exhibit 06: Global oncology molecular diagnostics market 2014-2019 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Reimbursement perspectives of healthcare entities
Exhibit 09: Factors influencing price of molecular diagnostic products
Exhibit 10: Global oncology molecular diagnostics market segmentation by cancer type
Exhibit 11: Global oncology molecular diagnostics market segmentation by cancer type 2014
Exhibit 12: Global oncology molecular diagnostics market by cancer type 2014 ($ millions)
Exhibit 13: Global oncology molecular diagnostics market segmentation by geography 2014
Exhibit 14: Global oncology molecular diagnostics market segmentation by geography 2019
Exhibit 15: Global oncology molecular diagnostics market by geography 2014-2019
Exhibit 16: Oncology molecular diagnostics market in Americas 2014-2019 ($ millions)
Exhibit 17: Oncology molecular diagnostics market in EMEA 2014-2019 ($ millions)
Exhibit 18: Oncology molecular diagnostics market in APAC 2014-2019 ($ millions)
Exhibit 19: Impact of drivers
Exhibit 20: Impact of drivers and challenges
Exhibit 21: Abbott: Key takeaways
Exhibit 22: Becton, Dickinson: Key takeaways
Exhibit 23: Qiagen: Key takeaways
Exhibit 24: Roche Diagnostics: Key takeaways
Exhibit 25: Abbott Diagnostics: Key business offerings
Exhibit 26: Becton, Dickinson: Business segmentation by revenue 2014
Exhibit 27: Becton, Dickinson: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: Becton, Dickinson: Geographical segmentation by revenue 2014
Exhibit 29: Segmentation of Qiagen's business by revenues 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.